A Prognostic Clinicopathologic Classification of Pituitary Endocrine Tumors
- 1 March 2015
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 44 (1) , 11-18
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatmentClinical Endocrinology, 2012
- Clinically silent somatotroph adenomas are commonEuropean Journal of Endocrinology, 2011
- Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegalyClinical Endocrinology, 2011
- Atypical pituitary adenomas: incidence, clinical characteristics, and implicationsJournal of Neurosurgery, 2011
- Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term OutcomesDiscover Oncology, 2010
- A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumorsEndocrine-Related Cancer, 2007
- What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and geneticsEuropean Journal of Endocrinology, 2007
- Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor RegistryEuropean Journal of Endocrinology, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgeryJournal of Neurosurgery, 2002